RDCCX
Price
$7.56
Change
+$0.49 (+6.93%)
Updated
Apr 9 closing price
Net Assets
153.85M
RMEBX
Price
$53.86
Change
+$3.35 (+6.63%)
Updated
Apr 9 closing price
Net Assets
92.19B
Ad is loading...

RDCCX vs RMEBX

Header iconRDCCX vs RMEBX Comparison
Open Charts RDCCX vs RMEBXBanner chart's image
Columbia Disciplined Value C
Price$7.56
Change+$0.49 (+6.93%)
VolumeN/A
Net Assets153.85M
American Funds American Mutual R2E
Price$53.86
Change+$3.35 (+6.63%)
VolumeN/A
Net Assets92.19B
RDCCX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RDCCX vs. RMEBX commentary
Apr 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RDCCX is a Hold and RMEBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 92.2B vs. RDCCX (154M). RMEBX pays higher dividends than RDCCX: RMEBX (1.18) vs RDCCX (0.69). RDCCX was incepted earlier than RMEBX: RDCCX (17 years) vs RMEBX (11 years). RDCCX (1.96) is less costly to investors than RMEBX (1.07). RDCCX is a more actively managed with annual turnover of: 60.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than RDCCX: RMEBX (250) vs RDCCX (2000). RMEBX annual gain was more profitable for investors over the last year : -4.38 vs. RDCCX (-15.57). RMEBX return over 5 years is better than : 44.36 vs. RDCCX (2.00).
RDCCXRMEBXRDCCX / RMEBX
Total Expense Ratio1.781.07166%
Annual Report Gross Expense Ratio1.961.07183%
Fund Existence17 years11 years-
Gain YTD-10.138-7.747131%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets154M92.2B0%
Annual Yield % from dividends0.691.1858%
Returns for 1 year-15.57-4.38356%
Returns for 3 years-17.04-1.071,586%
Returns for 5 years2.0044.365%
Returns for 10 years-20.2544.99-45%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTBP2.320.06
+2.65%
GT Biopharma
TARA3.750.05
+1.35%
Protara Therapeutics
LKQ38.54-0.97
-2.46%
LKQ Corp
PTLO10.52-0.34
-3.13%
Portillo's
OUT13.26-0.65
-4.67%
OUTFRONT Media Inc